MedPath

Wearable Devices to Promote Physical Activity

Not Applicable
Terminated
Conditions
Cardiovascular Diseases
Interventions
Behavioral: PAI group
Behavioral: Usual care
Registration Number
NCT03270202
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

This study evaluates the effect of a new wearable device, that measures physical activity level based on heart rates, on relevant health outcomes including cardiorespiratory fitness. Half of participants will be instructed in using the Mio Slice wristband, while the other half will be requested to follow today's recommendations for physical activity.

Detailed Description

Two critical challenges precluding the full potential of physical activity in preventive healthcare are: 1) The majority of people are not sufficiently active, and 2) there is a lack of large, long-term intervention studies documenting the effect of personalized activity and improved health in the population. Using HUNT data an algorithm called Personal Activity Intelligence (PAI) has been developed. PAI was integrated in a smartphone application and user friendly wristband (Mio Slice), that measures heart rate continuously and estimates an individual threshold for total physical activity (defined as 100 weekly PAI) that is associated with reduced risk of cardiovascular disease and mortality. The primary aim of the study is to reveal whether using the wristband will increase cardiorespiratory fitness, determined by maximal oxygen uptake, after 4 months among low-fit participants. The secondary aims includes the effect on reversing cardiovascular risk factors, cardiac structure and function, adherence to physical activity and identification of barriers after 16 weeks and 1 year.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
175
Inclusion Criteria
  • Participated in HUNT 3 and HUNT 4 Fitness Study
  • VO2peak in HUNT4 in the lowest sex- and age-specific tertile.
Exclusion Criteria
  • Illness or disabilities that preclude completion of the study or make exercise contraindicated
  • uncontrolled hypertension, arrhythmias or angina
  • heart failure
  • primary pulmonary hypertension
  • diagnosed dementia
  • chronic communicable infectious diseases
  • participation in conflicting interventions

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PAI groupUsual careParticipants randomized to the PAI-group will receive a wearable device (Mio Slice PAI wristband) that measure heart rate continuously and via an algorithm calculates a physical activity score called PAI. The weekly goal of 100 PAI can be reached by a combination of different intensities and durations and the participants will get continuous information about their current score and amount of activity needed to reach the goal. 100 PAI is expected to approximate current guidelines of 150 minutes of moderate intensity or 75 minutes of vigorous intensity for the average participant or somewhat less if the intensity of the chosen activity is high. Proper instruction in use of the device and App will be given both oral and written after baseline testing and randomization.
Usual careUsual careUsual care: Participants in the control group will be informed about, and encouraged to be active according to current recommendations for physical activity from the health authorities.
PAI groupPAI groupParticipants randomized to the PAI-group will receive a wearable device (Mio Slice PAI wristband) that measure heart rate continuously and via an algorithm calculates a physical activity score called PAI. The weekly goal of 100 PAI can be reached by a combination of different intensities and durations and the participants will get continuous information about their current score and amount of activity needed to reach the goal. 100 PAI is expected to approximate current guidelines of 150 minutes of moderate intensity or 75 minutes of vigorous intensity for the average participant or somewhat less if the intensity of the chosen activity is high. Proper instruction in use of the device and App will be given both oral and written after baseline testing and randomization.
Primary Outcome Measures
NameTimeMethod
Peak oxygen uptake (VO2peak)16 weeks

Measured by ergospirometry during a maximal treadmill protocol to exhaustion

Secondary Outcome Measures
NameTimeMethod
Adherence to prescribed physical activity1 year

Measured by Mio Slice

Quality of life1 year

Measured by questionnaire SF-36

Peak oxygen uptake (VO2peak)1 year

Measured by ergospirometry during a maximal treadmill protocol to exhaustion

Cardiovascular risk profile (ESC Score)1 year

Measured by blood samples and clinical data

Structural and functional cardiac changes1 year

Measured by echocardiography and CT coronary angiography

Feedback from users1 year

Measured by interviews and feedback systems

Trial Locations

Locations (1)

Department of Circulation and Medical Imaging

🇳🇴

Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath